[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-510846-105":59,"doc-detail-510846-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","arrive-guidelines-20-author-checklist-arrive-essential-10","ARRIVE guidelines 2.0 - author checklist - ARRIVE Essential 10","","The document provides the ARRIVE guidelines 2.0 author checklist, focusing on the ARRIVE Essential 10 items that ensure transparent reporting of animal experiments. It outlines required details for key study components including study design, sample size, inclusion and exclusion criteria, randomisation, blinding, outcome measures, statistical methods, experimental animals, and experimental procedures. It also summarizes expected reporting for results, including descriptive statistics and variability for each experimental group.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/arrive-guidelines-20-author-checklist-arrive-essential-10/510846/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/arrive-guidelines-20-author-checklist-arrive-essential-10/510846.png","ImageObject",300,407,{"name":92,"@type":93},"Grenda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-10-06",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What study design details does the ARRIVE Essential 10 checklist require?","Question",{"text":112,"@type":113},"It requires brief study design details for each experiment, including the groups being compared (including control groups) and the experimental unit, with the rationale if no control group was used.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How should sample size be reported?",{"text":117,"@type":113},"Specify the exact number of experimental units allocated to each group and the totals per experiment, indicate the total number of animals, and explain how the sample size was decided, including any a priori calculations if done.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the checklist request regarding randomisation and blinding?",{"text":121,"@type":113},"Randomisation should state whether it was used and the method for generating the randomisation sequence, while confounders should be minimized or explicitly reported if not controlled. Blinding should describe who knew group allocation at allocation, experiment conduct, outcome assessment, and data analysis, with outcome assessment and data analysis performed blinded to assignment where applicable.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},510846,1791856576,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":14,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":24,"preview_page_count":4},7971474921005,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","NOTE: Please save this file locally before filling in the table, DO NOT work on the file within your internet browser as changes will not be saved. Adobe Acrobat Reader (available free here) is recommended for completion.  \n The ARRIVE guidelines 2.0: author checklist  \nThe ARRIVE Essential 10  \n| Study design | 1 | For each experiment, provide brief details of study design including:\u003Cbr>a. The groups being compared, including control groups. If no control group has been used, the rationale should be stated.\u003Cbr>b. The experimental unit (e.g. a single animal, litter, or cage of animals). | Cage of animals, 6 rats per group.\u003Cbr>MATERIALS AND METHODS/Animal grouping and treatments/lines 1-5. |\n| --- | --- | --- | --- |\n| Sample size | 2 | a. Specify the exact number of experimental units allocated to each group, and the total number in each experiment. Also indicate the total number of animals used.\u003Cbr>b. Explain how the sample size was decided. Provide details of any a priori sample size calculation, if done. | Sample size calculation was not described in the manuscript. Group sizes were determined based on previous studies with similar experimental designs and on conventional practice in comparable animal\u003Cbr>MATERIALS AND METHODS/Animal grouping and treatments/lines 2-5. |\n| Inclusion and exclusion criteria | 3 | a. Describe any criteria used for including and excluding animals (or experimental units) during the experiment, and data points during the analysis. Specify if these criteria were established a priori. If no criteria were set, state this explicitly.\u003Cbr>b. For each experimental group, report any animals, experimental units or data points not included in the analysis and explain why. If there were no exclusions, state so.\u003Cbr>c. For each analysis, report the exact value of n in each experimental group. | No formal inclusion or exclusion criteria were predefined prior to the study. All animals, experimental units and data points obtained during the experiments were included in the final analysis.\u003Cbr>All animals, experimental units and data points obtained during the experiments were included in the final analysis.\u003Cbr>n = 6 per group for body weight; n = 3 per group for HE; n = 3 per group for IHC; n = 3 per group for RT-PCR. |\n| Randomisation | 4 | a. State whether randomisation was used to allocate experimental units to control and treatment groups. If done, provide the method used to generate the randomisation sequence.\u003Cbr>b. Describe the strategy used to minimise potential confounders such as the order of treatments and measurements, or animal/cage location. If confounders were not controlled, state this explicitly. | Although the detailed randomisation sequence was not described in the manuscript, all experimental groups were established under comparable baseline conditions and handled using the same experimental procedures to minimise potential bias.\u003Cbr>Potential confounders were minimised by maintaining identical housing and experimental conditions for all groups, although no formal confounder-control strategy was reported. |\n| Blinding | 5 | Describe who was aware of the group allocation at the different stages of the experiment (during the allocation, the conduct of the experiment, the outcome assessment, and the data analysis). | Group allocation was known only to personnel responsible for treatment administration. Outcome assessment and data analysis were performed blinded to group assignment. |\n| Outcome\u003Cbr>measures | 6 | a. Clearly define all outcome measures assessed (e.g. cell death, molecular markers, or behavioural changes).\u003Cbr>b. For hypothesis-testing studies, specify the primary outcome measure, i.e. the outcome measure that was used to determine the sample size. | Body weight changes, endometrial thickness, endometrial MVD, Cav-1, VEGF and β-catenin levels.\u003Cbr>Primary outcome measure not explicitly singled out. Multiple outcomes (histological, morphological, molecular ) presented without hierarchical d","cbCaiihxezvyYYfW","https://ap.wps.com/l/cbCaiihxezvyYYfW","pdf",264519,"English","# ARRIVE guidelines 2.0: author checklist\n## ARRIVE Essential 10\n### Study design\n### Sample size\n### Inclusion and exclusion criteria\n### Randomisation\n### Blinding\n### Outcome measures\n### Statistical methods\n### Experimental animals\n### Experimental procedures\n### Results","[{\"question\":\"What study design details does the ARRIVE Essential 10 checklist require?\",\"answer\":\"It requires brief study design details for each experiment, including the groups being compared (including control groups) and the experimental unit, with the rationale if no control group was used.\"},{\"question\":\"How should sample size be reported?\",\"answer\":\"Specify the exact number of experimental units allocated to each group and the totals per experiment, indicate the total number of animals, and explain how the sample size was decided, including any a priori calculations if done.\"},{\"question\":\"What does the checklist request regarding randomisation and blinding?\",\"answer\":\"Randomisation should state whether it was used and the method for generating the randomisation sequence, while confounders should be minimized or explicitly reported if not controlled. Blinding should describe who knew group allocation at allocation, experiment conduct, outcome assessment, and data analysis, with outcome assessment and data analysis performed blinded to assignment where applicable.\"}]","ARRIVE guidelines 2.0 - author checklist - ARRIVE Essential 10 | PDF",1791245571]